375 related articles for article (PubMed ID: 16615993)
1. Mode of action of the new antibiotic for Gram-positive pathogens daptomycin: comparison with cationic antimicrobial peptides and lipopeptides.
Straus SK; Hancock RE
Biochim Biophys Acta; 2006 Sep; 1758(9):1215-23. PubMed ID: 16615993
[TBL] [Abstract][Full Text] [Related]
2. Short cationic lipopeptides as effective antibacterial agents: Design, physicochemical properties and biological evaluation.
Azmi F; Elliott AG; Marasini N; Ramu S; Ziora Z; Kavanagh AM; Blaskovich MA; Cooper MA; Skwarczynski M; Toth I
Bioorg Med Chem; 2016 May; 24(10):2235-41. PubMed ID: 27048775
[TBL] [Abstract][Full Text] [Related]
3. New Paenibacillus strain produces a family of linear and cyclic antimicrobial lipopeptides: cyclization is not essential for their antimicrobial activity.
Huang E; Yang X; Zhang L; Moon SH; Yousef AE
FEMS Microbiol Lett; 2017 Apr; 364(8):. PubMed ID: 28333237
[TBL] [Abstract][Full Text] [Related]
4. The efficacy and safety of daptomycin: first in a new class of antibiotics for Gram-positive bacteria.
Rybak MJ
Clin Microbiol Infect; 2006 Mar; 12 Suppl 1():24-32. PubMed ID: 16445721
[TBL] [Abstract][Full Text] [Related]
5. The action mechanism of daptomycin.
Taylor SD; Palmer M
Bioorg Med Chem; 2016 Dec; 24(24):6253-6268. PubMed ID: 27288182
[TBL] [Abstract][Full Text] [Related]
6. A liaR deletion restores susceptibility to daptomycin and antimicrobial peptides in multidrug-resistant Enterococcus faecalis.
Reyes J; Panesso D; Tran TT; Mishra NN; Cruz MR; Munita JM; Singh KV; Yeaman MR; Murray BE; Shamoo Y; Garsin D; Bayer AS; Arias CA
J Infect Dis; 2015 Apr; 211(8):1317-25. PubMed ID: 25362197
[TBL] [Abstract][Full Text] [Related]
7. Estimation of the subunit stoichiometry of the membrane-associated daptomycin oligomer by FRET.
Muraih JK; Palmer M
Biochim Biophys Acta; 2012 Jul; 1818(7):1642-7. PubMed ID: 22387459
[TBL] [Abstract][Full Text] [Related]
8. Daptomycin: a lipopeptide antibiotic for the treatment of serious Gram-positive infections.
Steenbergen JN; Alder J; Thorne GM; Tally FP
J Antimicrob Chemother; 2005 Mar; 55(3):283-8. PubMed ID: 15705644
[TBL] [Abstract][Full Text] [Related]
9. Mechanisms of drug resistance: daptomycin resistance.
Tran TT; Munita JM; Arias CA
Ann N Y Acad Sci; 2015 Sep; 1354():32-53. PubMed ID: 26495887
[TBL] [Abstract][Full Text] [Related]
10. [Daptomycin, the first cydal antibiotic of a new class active against Gram positive pathogens].
Stefani S; Esposito S
Infez Med; 2006 Dec; 14(4):179-96. PubMed ID: 17380085
[TBL] [Abstract][Full Text] [Related]
11. Daptomycin avoids drug resistance mediated by the BceAB transporter in
Faure A; Manuse S; Gonin M; Grangeasse C; Jault J-M; Orelle C
Microbiol Spectr; 2024 Feb; 12(2):e0363823. PubMed ID: 38214521
[TBL] [Abstract][Full Text] [Related]
12. Antimicrobial activity of daptomycin against multidrug-resistant Gram-positive strains collected worldwide.
Sader HS; Streit JM; Fritsche TR; Jones RN
Diagn Microbiol Infect Dis; 2004 Nov; 50(3):201-4. PubMed ID: 15541606
[TBL] [Abstract][Full Text] [Related]
13. Daptomycin: Physicochemical, Analytical, and Pharmacological Properties.
Tótoli EG; Garg S; Salgado HR
Ther Drug Monit; 2015 Dec; 37(6):699-710. PubMed ID: 26020161
[TBL] [Abstract][Full Text] [Related]
14. [Comparative in vitro activity of daptomycin against gram-positive microorganisms: SENTRY surveillance program, Spain (2002-2006)].
Loza E; Morosini MI; Pascual A; Tubau F; Alcalá J; Liñares J; Hernández-Bello JR; Baquero F; Perea E; Martín R; Jones RN; Cantón R;
Enferm Infecc Microbiol Clin; 2008 Oct; 26(8):489-94. PubMed ID: 19094861
[TBL] [Abstract][Full Text] [Related]
15. [Daptomycin: revitalizing a former drug due to the need of new active agents against grampositive multiresistant bacterias].
Hernández Martí V; Romá Sánchez E; Salavert Lletí M; Bosó Ribelles V; Poveda Andrés JL
Rev Esp Quimioter; 2007 Sep; 20(3):261-76. PubMed ID: 18080024
[TBL] [Abstract][Full Text] [Related]
16. Antimicrobial activity and spectrum of daptomycin: results from the surveillance program in Australia and New Zealand (2008).
Bell JM; Turnidge JD; Sader HS; Jones RN
Pathology; 2010; 42(5):470-3. PubMed ID: 20632825
[TBL] [Abstract][Full Text] [Related]
17. Natural products to drugs: daptomycin and related lipopeptide antibiotics.
Baltz RH; Miao V; Wrigley SK
Nat Prod Rep; 2005 Dec; 22(6):717-41. PubMed ID: 16311632
[TBL] [Abstract][Full Text] [Related]
18. Proline-rich antimicrobial peptides: potential therapeutics against antibiotic-resistant bacteria.
Li W; Tailhades J; O'Brien-Simpson NM; Separovic F; Otvos L; Hossain MA; Wade JD
Amino Acids; 2014 Oct; 46(10):2287-94. PubMed ID: 25141976
[TBL] [Abstract][Full Text] [Related]
19. Cyclic lipopeptides as antibacterial agents - potent antibiotic activity mediated by intriguing mode of actions.
Schneider T; Müller A; Miess H; Gross H
Int J Med Microbiol; 2014 Jan; 304(1):37-43. PubMed ID: 24119568
[TBL] [Abstract][Full Text] [Related]
20. [Daptomycin in the context of antimicrobial resistance in Gram-positive bacteria].
Candel González FJ
Enferm Infecc Microbiol Clin; 2012 Feb; 30 Suppl 1():10-6. PubMed ID: 22541970
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
